The global dementia drugs market is anticipated to grow at a significant CAGR around 8.1% during the forecast period. The global dementia drugs market is largely driven due to the increasing prevalence of target diseases, the introduction of new and innovative technologies and drugs, and increased government funding and awareness programs for dementia. Also, several market players are engaged in the implementation of strategic developments. For instance, in Feb 2020 a new initiative by McGill University’s Dementia Education Program is among the 15 projects that will receive funding from the public health agency of Canada to raise awareness of dementia and promote dementia-inclusive communities. For instance, in October 2021, the government in Kerala, India, launched the Dementia-Friendly District program, ‘Udbodh’.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/dementia-drugs-market-size
This initiative has been taken with a collaboration between Cochin University of Science and Technology’s NeuroScience department, in the Ernakulam district administration as well as Kochi Municipal Corporation. In Jan 2021 LSP the leading European life science investor launched the LSP Dementia Fund, a fund that is dedicated to combating neurodegenerative diseases. Such Initiatives will boost the awareness of dementia drugs, thereby contributing to market growth. However, factor such as high failure rates of drugs at the approval stage is expected to delay market growth over the forecast period.
Market Coverage
- The market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Dementia Type
- By Drugs Type
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Land- Teva Pharmaceuticals Industries Ltd., Merck & Co. Inc., Pfizer Inc., GlaxoSmithKline Plc, Aurobindo Pharma Ltd., Biogen Inc., and others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How does COVID-19 impact the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
A full report of Global Dementia Drugs Market available @ https://www.omrglobal.com/industry-reports/dementia-drugs-market-size
Dementia Drugs Market Segmentation
By Dementia Type
- Lewy Body Dementia
- Parkison’s Disease Dementia
- Alzheimer’s Disease Dementia
- Others
By Drugs Type
- Cholinesterase Inhibitors
- MAO Inhibitors
- GlutamateInhibitors
- Others
